Selection of the site: a medicine for the treatment of onychomycosis

Our site has been selected to participate in the study of a new medicine for the treatment of fungal nail lesions. Patients will be monitored for about a year and will receive not only the most modern treatment, but also regular medical pedicure.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen